The Mumbai-based drugmaker, in a regulatory filing, said it has the rights to distribute and promote Yurpeak, the second anti ...

Welcome to the Cipla Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...

Track 10 key stocks including IndiGo, LIC, Cipla, and TCS for major news and market updates—see which companies are making ...

The Delhi facility offers over 60 advanced tests and aims to close critical gaps in respiratory diagnosis and care ...

Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...

Commenting on the launch, Achin Gupta, Global Chief Operating Officer, Cipla Limited, said, "The launch of Yurpeak marks a transformative moment in the fight against obesity and type 2diabetes ...

Cipla subsidiary InvaGen issued a voluntary recall of one lot of the oral anti-seizure drug vigabatrin due to problems with seal integrity in its packaging. The recalled lot of the medication, which ...

Stay up-to-date with the Cipla Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent ...

Cipla launches Breathefree Lung Wellness Center in Delhi, offering advanced diagnostics and comprehensive services for respiratory health.

New Delhi : Pharma major Cipla Ltd on Friday said it will acquire 21.05 per cent stake for Rs 25 crore in Achira Labs Pvt Ltd, which is engaged in development and commercialisation of point of care ...

Cipla said there was no new development requiring additional disclosure on the matter. The sharp fall in Cipla shares on Thursday was triggered by concerns about whether the warning letter will impact ...

The centre will provide a comprehensive gamut of over 60 tests covering lung physiology, microbiology, immunology, blood chemistry and radiology ...